Triglyceride accumulation and altered composition of triglyceride-associated fatty acids in the skin of tenascin-X-deficient mice

Genes to Cells

Volumn 9, Issue 8, 2004, Pages 737-748

  Matsumoto, Ken Ichi ^a   Sato, Takashige ^a   Oka, Seiko ^a   Orba, Yasuko ^b   Sawa, Hirofumi ^b   Kabayama, Kazuya ^a   Inokuchi, Jin Ichi ^a   Ariga, Hiroyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; LINOLEIC ACID; OLEIC ACID; PALMITIC ACID; PALMITOLEIC ACID; SATURATED FATTY ACID; STEARIC ACID; TENASCIN; TRIACYLGLYCEROL; UNSATURATED FATTY ACID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CELL LINE; CONTROLLED STUDY; ESSENTIAL FATTY ACID DEFICIENCY; FATTY ACID ANALYSIS; FIBROBLAST; GAS CHROMATOGRAPHY; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC TRANSFECTION; HISTOLOGY; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIPOGENESIS; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SKIN DEFECT; SKIN DISEASE; THIN LAYER CHROMATOGRAPHY; TRIACYLGLYCEROL BLOOD LEVEL; WILD TYPE;

ADIPOSE TISSUE; ANIMALS; ENZYMES; FATTY ACIDS; LIPID METABOLISM; MICE; MICE, KNOCKOUT; SKIN; SUBCUTANEOUS TISSUE; TENASCIN; TRIGLYCERIDES;

EID: 4444317052     PISSN: 13569597     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1356-9597.2004.00755.x     Document Type: Article

References (40)

1. Alexander, C.M., Selvarajan, S., Mudgett, J. & Werb, Z. (2001) Stromelysin-1 regulates adipogenesis during mammary gland involution. J. Cell Biol. 152, 693-703.
2. Bouloumié, A., Sengenés, C., Portolan, G., Galitzky, J. & Lafontan, M. (2001) Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes 50, 2080-2086.
3. Bristow, J., Tee, M.K., Gitelman, S.E., Mellon, S.H. & Miller, W.L. (1993) Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B. J. Cell Biol. 122, 265-278.
4. Burch, G.H., Bedolli, M.A., McDonough, S., Rosenthal, S.M. & Bristow, J. (1995) Embryonic expression of tenascin-X suggests a role in limb, muscle, and heart development. Dev. Dyn. 203, 491-504.
5. Burch, G.H., Gong, Y., Liu, W., et al. (1997) Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nature Genet. 17, 104-108.
6. Chiquet-Ehrismann, R. & Chiquet, M. (2003) Tenascins: regulation and putative functions during pathological stress. J. Pathol. 200, 488-499.
7. Chiquet-Ehrismann, R., Hagios, C. & Matsumoto, K. (1994) The tenascin gene family. Perspect. Dev. Neurobiol. 2, 3-7.
8. Croissandeau, G., Chretien, M. & Mbikay, M. (2002) Involvement of matrix metalloproteinases in the adipose conversion of 3T3-L1 preadipocytes. Biochem. J. 364, 739-746.
9. Erickson, H.P. (1993) Tenascin-C, tenascin-R. and tenascin-X: a family of talented proteins in search of functions. Curr. Opin. Cell Biol. 5, 869-876.
10. Ganser, G.L., Stricklin, G.P. & Matrisian, L.M. (1991) EGF and TGF alpha influence in vitro lung development by the induction of matrix-degrading metalloproteinases. Int. J. Dev. Biol. 35, 453-461.
11. Hagios, C., Koch, M., Spring, J., Chiquet, M. & Chiquet-Ehrismann, R. (1996) Tenascin-Y: a protein of novel domain structure is secreted by differentiated fibroblasts of muscle connective tissue. J. Cell Biol. 134, 1499-1512.
12. Hotamisligil, G.S., Shargill, N.S. & Spiegelman, B.M. (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87-91.
13. Ikuta, T., Ariga, H. & Matsumoto, K. (2000) Extracellular matrix tenascin-X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation. Genes Cells 5, 913-927.
14. Ikuta, T., Sogawa, N., Ariga, H., Ikemura, T. & Matsumoto, K. (1998) Structural analysis of mouse tenascin-X: evolutionary aspects of reduplication of FNIII repeats in the tenascin gene family. Gene 217, 1-13.
15. Jones, P.L. & Jones, F.S. (2000) Tenascin-C in development and disease: gene regulation and cell function. Matrix Biol. 19, 581-596.
16. Ladisch, S. & Gillard, B. (1985) A solvent partition method for microscale ganglioside purification. Anal. Biochem. 146, 220-231.
17. Lethias, C., Descollonges, Y., Boutillon, M.M. & Garrone, R. (1996) Flexilin: a new extracellular matrix glycoprotein localized on collagen fibrils. Matrix Biol. 15, 11-19.
18. Mao, J.R. & Bristow, J. (2001) The Ehlers-Danlos syndrome: on beyond collagens. J. Clin. Invest. 107, 1063-1069.
19. Mao, J.R., Taylor, G., Dean, W.B., et al. (2002) Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition. Nature Genet. 30, 421-425.
20. Matsumoto, K., Arai, M., Ishihara, N., et al. (1992a) Cluster of fibronectin type III repeats found in the human major histocompatibility complex class III region shows the highest homology with the repeats in an extracellular matrix protein, tenascin. Genomics 12, 485-491.
21. Matsumoto, K., Ishihara, N., Ando, A., Inoko, H. & Ikemura, T. (1992b) Extracellular matrix protein tenascin-like gene found in human MHC class III region. Immunogenetics 36, 400-403.
22. Matsumoto, K., Saga, Y., Ikemura, T., Sakakura, T. & Chiquet-Ehrismann, R. (1994) The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C. J. Cell Biol. 125, 483-493.
23. Matsumoto, K., Takayama, N., Ohnishi, J., et al. (2001) Tumour invasion and metastasis are promoted in mice deficient in tenascin-X. Genes Cells 6, 1101-1111.
24. Matsumoto, K., Sawa, H., Sato, M., et al. (2002a) Distribution of extracellular matrix tenascin-X in sciatic nerves. Acta Neuropathol. 104, 448-454.
25. Matsumoto, K., Takahashi, K., Yoshiki, A., Kusakabe, M. & Ariga, H. (2002b) Invasion of melanoma in double knockout mice lacking tenascin-X and tenascin-C. Jpn. J. Cancer Res. 93, 968-975.
26. Matsumoto, K., Minamitani, T., Orba, Y., et al. (2004) Induction of matrix metalloproteinase-2 by tenascin-X deficiency is mediated through the c-Jun N-terminal kinase and protein tyrosine kinase phosphorylation pathway. Exp. Cell Res., in press.
27. Minamitani, T., Ariga, H. & Matsumoto, K. (2000) Transcription factor Sp1 activates the expression of the mouse tenascin-X gene. Biochem. Biophys. Res. Commun. 267, 626-631.
28. Minamitani, T., Ariga, H. & Matsumoto, K. (2004) Deficiency of tenascin-X causes a decrease in the level of expression of type VI collagen. Exp. Cell Res. 297, 49-60.
29. Morel, Y., Bristow, J., Gitelman, S.E. & Miller, W.L. (1989) Transcript encoded on the opposite strand of the human steroid 21-hydroxylase/complement component C4 gene locus. Proc. Natl. Acad. Sci. USA 86, 6582-6586.
30. Mosher, D.F., Sottile, J., Wu, C. & McDonald, J.A. (1992) Assembly of extracellular matrix. Curr. Opin. Cell Biol. 4, 810-818.
31. Nakajima, I., Muroya, S., Tanabe, R. & Chikuni, K. (2002) Positive effect of collagen V and VI on triglyceride accumulation during differentiation in cultures of bovine intramuscular adipocytes. Differentiation 70, 84-91.
32. Neidhardt, J., Fehr, S., Kutsche, M., Lohler, J. & Schachner, M. (2003) Tenascin-N: characterization of a novel member of the tenascin family that mediates neurite repulsion from hippocampal explants. Mol. Cell. Neurosci. 23, 193-209.
33. Schalkwijk, J., Zweers, M.C., Steijlen, P.M., et al. (2001) A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N. Engl. J. Med. 345, 1167-1175.
34. Shapiro, S.D. (1998) Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr. Opin. Cell Biol. 10, 602-608.
35. Stetler-Stevenson, W.G., Aznavoorian, S. & Liotta, L.A. (1993) Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9, 541-573.
36. Sympson, C.J., Talhouk, R.S., Alexander, C.M., et al. (1994) Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J. Cell Biol. 125, 681-693.
37. Tagami, S., Inokuchi, J., Kabayama, K., et al. (2002) Ganglioside GM3 participates in the pathological conditions of insulin resistance. J. Biol. Chem. 277, 3085-3092.
38. Wang, X.Q., Sun, P. & Paller, A.S. (2003) Ganglioside GM3 inhibits matrix metalloproteinase-9 activation and disrupts its association with integrin. J. Biol. Chem. 278, 25591-25599.
39. Weber, P., Montag, D., Schachner, M. & Bernhardt, R.R. (1998) Zebrafish tenascin-W, a new member of the tenascin family. J. Neurobiol. 35, 1-16.
40. Zangani, D., Darcy, K.M., Masso-Welch, P.A., et al. (1999) Multiple differentiation pathways of rat mammary stromal cells in vitro: acquisition of a fibroblast, adipocyte or endothelial phenotype is dependent on hormonal and extracellular matrix stimulation. Differentiation 64, 91-101.